New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Mark Cuban: A Master Disrupter for American Health...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
High-speed imaging tracks live brain cell activity...
World is falling behind on UN's child mortality Sustainable ...
April 16,2026
Health literacy initiative improves discharge education, rea...
April 15,2026
Constipation is common, but with simple changes, you can man...
April 14,2026
Children and teenagers more open to meat free diets—but stru...
April 13,2026
3D-printed ATLAS platform helps model cancer cell clusters b...
April 12,2026
3 million-cell map shows menopause reshapes breast tissue, p...
April 11,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Today's News
Why is Alzheimer’s disease so difficult to treat? ...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Novel mechanism of ILC2 immune cell development may be involved in exacerbating allergic diseases

Novel mechanism of ILC2 immune cell development may be involved in exacerbating allergic diseases

byChiba UniversityResearchers identify a G3SE-dependent mechanism of ILC2 development. Credit: Yosuke Toda and Arifumi Iwata from Chiba UniversityOverproduction of Group 2 innate lymphoid cells
Immunology & Rheumatology July 11,2024
Novel mechanism of ILC2 immune cell development may be involved in exacerbating allergic diseases

Novel mechanism of ILC2 immune cell development may be involved in exacerbating allergic diseases

byChiba UniversityResearchers identify a G3SE-dependent mechanism of ILC2 development. Credit: Yosuke Toda and Arifumi Iwata from Chiba UniversityOverproduction of Group 2 innate lymphoid cells
Immunology & Rheumatology July 11,2024
Study finds cirrhosis affects twice as many transgender adults as cisgender adults

Study finds cirrhosis affects twice as many transgender adults as cisgender adults

byUniversity of Southern CaliforniaCredit:American Journal of Gastroenterology(2024). DOI: 10.14309/ajg.0000000000002907Cirrhosis is chronic, progressive end-stage liver disease that
Hepatobiliary&Pancreas Surgery July 11,2024
Study finds cirrhosis affects twice as many transgender adults as cisgender adults

Study finds cirrhosis affects twice as many transgender adults as cisgender adults

byUniversity of Southern CaliforniaCredit:American Journal of Gastroenterology(2024). DOI: 10.14309/ajg.0000000000002907Cirrhosis is chronic, progressive end-stage liver disease that
Hepatobiliary&Pancreas Surgery July 11,2024
Researcher details risk factors for chronic kidney disease and barriers for early detection

Researcher details risk factors for chronic kidney disease and barriers for early detection

by Caitlin Hanbury,Virginia Commonwealth UniversityThe community-based research on kidney disease screenings and risk factors is coordinated by affiliate researcher Amber Paulus, Ph.D., R.N. Cre
Nephrology & Urology July 11,2024
Researcher details risk factors for chronic kidney disease and barriers for early detection

Researcher details risk factors for chronic kidney disease and barriers for early detection

by Caitlin Hanbury,Virginia Commonwealth UniversityThe community-based research on kidney disease screenings and risk factors is coordinated by affiliate researcher Amber Paulus, Ph.D., R.N. Cre
Nephrology & Urology July 11,2024
AI model can predict continuous renal replacement therapy survival

AI model can predict continuous renal replacement therapy survival

byUniversity of California, Los AngelesOverview of study design and machine learning framework. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-49763-3A UCLA-led team has
Nephrology & Urology July 11,2024
AI model can predict continuous renal replacement therapy survival

AI model can predict continuous renal replacement therapy survival

byUniversity of California, Los AngelesOverview of study design and machine learning framework. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-49763-3A UCLA-led team has
Nephrology & Urology July 11,2024
Cystic fibrosis: School-aged children found to benefit from triple combination therapy

Cystic fibrosis: School-aged children found to benefit from triple combination therapy

byCharité - Universitätsmedizin BerlinMRI images of a child with cystic fibrosis: Mucus deposits, widening of the bronchi, and thickening of the bronchial walls are clearly visible in the lungs
Pulmonology July 11,2024
Cystic fibrosis: School-aged children found to benefit from triple combination therapy

Cystic fibrosis: School-aged children found to benefit from triple combination therapy

byCharité - Universitätsmedizin BerlinMRI images of a child with cystic fibrosis: Mucus deposits, widening of the bronchi, and thickening of the bronchial walls are clearly visible in the lungs
Pulmonology July 11,2024
Optimized diagnosis of neuroborreliosis using signaling protein as a biomarker

Optimized diagnosis of neuroborreliosis using signaling protein as a biomarker

by Karl Landsteiner University of Health SciencesCredit: Erik Karits from PexelsA newly defined threshold for the concentration of the cytokine CXCL13 may improve the diagnosis of neuroborreliosis. Th
Neurology July 11,2024
Optimized diagnosis of neuroborreliosis using signaling protein as a biomarker

Optimized diagnosis of neuroborreliosis using signaling protein as a biomarker

by Karl Landsteiner University of Health SciencesCredit: Erik Karits from PexelsA newly defined threshold for the concentration of the cytokine CXCL13 may improve the diagnosis of neuroborreliosis. Th
Neurology July 11,2024
Aging exacerbates oxidative stress and liver fibrosis in an animal model of Down Syndrome

Aging exacerbates oxidative stress and liver fibrosis in an animal model of Down Syndrome

by Impact Journals LLCDS mice show a marked increase in fibrotic markers. Credit:Aging(2024). DOI: 10.18632/aging.205970A new research paper titled "Aging exacerbates oxidative stress
Hepatobiliary&Pancreas Surgery July 11,2024
Aging exacerbates oxidative stress and liver fibrosis in an animal model of Down Syndrome

Aging exacerbates oxidative stress and liver fibrosis in an animal model of Down Syndrome

by Impact Journals LLCDS mice show a marked increase in fibrotic markers. Credit:Aging(2024). DOI: 10.18632/aging.205970A new research paper titled "Aging exacerbates oxidative stress
Hepatobiliary&Pancreas Surgery July 11,2024
Scientists discover two cellular defects appear to drive disease in lupus

Scientists discover two cellular defects appear to drive disease in lupus

byNorthwestern UniversityCredit: Pixabay/CC0 Public DomainNorthwestern Medicine and Brigham and Women's Hospital scientists have discovered a molecular defect that promotes the pathologic im
Immunology & Rheumatology July 11,2024
Scientists discover two cellular defects appear to drive disease in lupus

Scientists discover two cellular defects appear to drive disease in lupus

byNorthwestern UniversityCredit: Pixabay/CC0 Public DomainNorthwestern Medicine and Brigham and Women's Hospital scientists have discovered a molecular defect that promotes the pathologic im
Immunology & Rheumatology July 11,2024
Scientists discover a new hormone that could build strong bones

Scientists discover a new hormone that could build strong bones

byUniversity of California, San FranciscoCredit: Unsplash/CC0 Public DomainResearchers at UCSF and UC Davis have solved a long-standing puzzle on how the bones of breastfeeding women stay strong
Orthopedics & Sports medicine July 11,2024
Scientists discover a new hormone that could build strong bones

Scientists discover a new hormone that could build strong bones

byUniversity of California, San FranciscoCredit: Unsplash/CC0 Public DomainResearchers at UCSF and UC Davis have solved a long-standing puzzle on how the bones of breastfeeding women stay strong
Orthopedics & Sports medicine July 11,2024
New discovery could help treat a rare and severe form of amyloidosis

New discovery could help treat a rare and severe form of amyloidosis

byWileyPET scan of a human brain with Alzheimer's disease. Credit: public domainIn people with a rare condition called light chain amyloidosis, light chain proteins—which are a component of
Neurology July 11,2024
New discovery could help treat a rare and severe form of amyloidosis

New discovery could help treat a rare and severe form of amyloidosis

byWileyPET scan of a human brain with Alzheimer's disease. Credit: public domainIn people with a rare condition called light chain amyloidosis, light chain proteins—which are a component of
Neurology July 11,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu... ... Eye Infections (Updated) | Clinical Medicine ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com